← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Metafold Therapeutics, Inc.
San Francisco, CA
$562,684
Total funding
3
Grants
Funding over time
peak $196.7K · FY2009–12$200K$150K$100K$50K$0
'09
'10
'11
'12
Funding mix
By agency
NIH$562,684 · 3
By mechanism
R41$377,908 · 2
R43$184,776 · 1
Investigators at Metafold Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Developing UPR Modulators as Novel Therapeutics for Neurodegeneration$196,688
R41 · FY2011 · NS
Inflammasome Inhibitors for Type 2 Diabetes$184,776
R43 · FY2012 · DK
Cytoprotective Effects of UPR Modulators in ER Stress-Challenged beta-Cells$152,520
R41 · FY2009 · DK
Cytoprotective Effects of UPR Modulators in ER Stress-Challenged beta-Cells$28,700
R41 · FY2009 · DK